Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Dexrazoxane hydrochloride 500mg/vial powder |
Is a |
Cytoprotective agent |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Dexrazoxane hydrochloride 500mg/vial powder |
Is a |
Medicinal product acting as antidote agent (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Dexrazoxane hydrochloride 500mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
agent cytoprotecteur |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Dexrazoxane hydrochloride 500mg/vial powder |
Is a |
Dexrazoxane hydrochloride |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Dexrazoxane hydrochloride 500mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Substance with chelating agent mechanism of action (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Dexrazoxane hydrochloride 500mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Dexrazoxane |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Dexrazoxane hydrochloride 500mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Razoxane (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Dexrazoxane hydrochloride 500mg/vial powder |
Has manufactured dose form |
Injection (product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Dexrazoxane hydrochloride 500mg/vial powder |
Is a |
Product manufactured as parenteral dose form |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Dexrazoxane hydrochloride 500mg/vial powder |
Is a |
Dexrazoxane-containing product |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|